Trial · NCT03087201
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response-rate to treatment according to YGTSS-TTS (Total Tic-Score of the Yale Global Tic Severity Scale [YGTSS]) | 13 weeks | |
| Secondary | Fitness to Drive Test | 13 weeks | Reaction time and choice reaction (RT) |
| Secondary | Fitness to Drive Test | 13 weeks | Stress Behavior capacity (DT-Auslastung) |
| Secondary | Fitness to Drive Test | 13 weeks | Stress Behavior performance quantity (DT Mengenleistung) |
| Secondary | Fitness to Drive Test | 13 weeks | Concentration (COG) |
| Secondary | Fitness to Drive Test | 13 weeks | Perceptual speed (ATAVT) |
| Secondary | YGTSS-TTS | 8 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | YGTSS-TTS | Baseline and 13 weeks | |
| Secondary | YGTSS-Global Score (YGTSS-GS) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Modified Rush Video-Based Tic Rating Scale (MRVS) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Clinical Global Impression-Improvement Score (CGI-I) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Clinical Global Impression-Severity Score (CGI-S) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Adult Tic Questionnaire (ATQ) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Tourette Syndrome-Quality of Life Scale (GTS-QoL) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Pre-monitory Urge for Tics Scale (PUTS) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Beck Depression Inventory-II (BDI-II) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Yale-Brown Obsessive Compulsive Scale (Y-BOCS) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Conners' Adult ADHD Rating Scale (CAARS) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Beck Anxiety Inventory (BAI) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) | |
| Secondary | Pittsburgh Sleep Quality Index (PSQI) | 8 weeks, 13 weeks and 1 month after end of treatment (17 weeks) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03087201/registered